Prognostic value of coronary vascular endothelial dysfunction

Circulation

Volumn 106, Issue 6, 2002, Pages 653-658

  Halcox, Julian P J ^a   Schenke, William H ^a   Zalos, Gloria ^a   Mincemoyer, Rita ^a   Prasad, Abhiram ^a   Waclawiw, Myron A ^a   Nour, Khaled R A ^a   Quyyumi, Arshed A ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Atherosclerosis; Coronary disease; Endothelium; Infarction; Prognosis

Indexed keywords

ACETYLCHOLINE; ADENOSINE; NITROPRUSSIDE SODIUM;

ADULT; AGE; ARTERY ENDOTHELIUM; ARTICLE; BODY MASS; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY RISK; CORONARY VASCULAR RESISTANCE; EPICARDIUM; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STROKE; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; CEREBROVASCULAR ACCIDENT; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; CORONARY VESSELS; DISEASE-FREE SURVIVAL; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; PERICARDIUM; PROGNOSIS; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 0037031266     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000025404.78001.D8     Document Type: Article

References (22)

1. Endothelial function in health and disease: New insights into the genesis of cardiovascular disease
2. Contribution of bradykinin receptor dysfunction to abnormal coronary vasomotion in humans
3. Nitric oxide activity in the human coronary circulation: Impact of risk factors for coronary atherosclerosis
4. Nitric oxide activity in the atherosclerotic human coronary circulation
5. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
6. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
7. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity
8. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
9. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress
10. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity
11. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
12. The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man
13. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: Direct link between endothelial dysfunction and atherothrombosis
14. Endothelium-dependent vasodilation and tissue-type plasminogen activator release in borderline hypertension
15. Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans
16. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase
17. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: Implications for atherosclerotic plaque stability
18. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
19. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
20. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
21. Collaborative overview of randomised trials of antiplatelet therapy, I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients